Rhinomed Limited
RHNMF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $18,523 | $30,546 | $39,441 | $11,003 |
| - Cash | $190 | $1,989 | $2,340 | $7,757 |
| + Debt | $5,976 | $337 | $470 | $588 |
| Enterprise Value | $24,308 | $28,894 | $37,572 | $3,834 |
| Revenue | $7,472 | $9,105 | $3,895 | $3,565 |
| % Growth | -17.9% | 133.8% | 9.2% | – |
| Gross Profit | -$190 | $6,206 | $2,753 | $2,115 |
| % Margin | -2.5% | 68.2% | 70.7% | 59.3% |
| EBITDA | -$9,096 | -$4,536 | -$8,005 | -$6,677 |
| % Margin | -121.7% | -49.8% | -205.5% | -187.3% |
| Net Income | -$10,908 | -$5,281 | -$8,639 | -$7,266 |
| % Margin | -146% | -58% | -221.8% | -203.8% |
| EPS Diluted | -0.038 | -0.02 | -0.034 | -0.044 |
| % Growth | -89.1% | 40.2% | 23.2% | – |
| Operating Cash Flow | -$7,178 | -$5,743 | -$5,335 | -$5,740 |
| Capital Expenditures | -$95 | -$877 | -$49 | -$11 |
| Free Cash Flow | -$7,273 | -$877 | -$49 | -$5,751 |